Statistics for Creo Medical Group plc (id:3907 CREO)

Valuation metrics

Market cap

66.97M

Enterprise value

64.98M

Trailing P/E (ttm)

-237.50

Forward P/E

-0.06

PEG ratio

-0.06

Price/Sales (ttm)

2.21

Price/Book (mrq)

124.05

Enterprise Value/Revenue

2.14

Enterprise Value/EBITDA

-2.86

Overview

Shares outstanding

412.15M

Float

325.96M

Shares short

% Held by insiders

0.20%

% Held by institutions

0.49%

Average volume (10 days)

1.27M

Average volume (90 days)

Price summary

52-Week low

15.70

52-Week high

50.00

52-Week change

-93.98%

Beta

0.85

50-Day moving average

22.24

200-Day moving average

30.65

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-73.93%

Operating margin

-89.47%

Operational effectiveness

Return on assets

-20.10%

Return on equity

-38.49%

Income statement

Revenue (ttm)

0.08

Revenue per share (ttm)

0.08

Quarterly revenue growth (yoy)

Gross profit (ttm)

15.30M

EBITDA

-22,700,000.00

Net income to common (ttm)

-22,400,000.00

Diluted EPS (ttm)

-0.06

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

9.80M

Total cash per share (mrq)

0.03

Total debt (mrq)

14.20M

Total Debt/Equity (mrq)

29.96

Current ratio (mrq)

324.20%

Book value per share (mrq)

0.13

Cash flow

Cash flow statement

-20,100,000.00

Levered free cash flow (LFCF)

-14,950,000.00